Dr. Sanjay Maraboyina
Claim this profileUniversity of Arkansas for Medical Sciences
Studies Prostate Cancer
Studies Prostate Adenocarcinoma
9 reported clinical trials
37 drugs studied
Affiliated Hospitals
Clinical Trials Sanjay Maraboyina is currently running
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3
Shorter vs Usual Radiation Therapy
for Prostate Cancer
This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period of time. This trial is evaluating if shorter duration radiation prevents cancer from coming back as well as the usual radiation treatment.
Recruiting2 awards Phase 310 criteria
More about Sanjay Maraboyina
Clinical Trial Related6 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Sanjay Maraboyina has experience with
- Stereotactic Body Radiation Therapy
- Atezolizumab
- Apalutamide
- Degarelix
- Histrelin
- Bicalutamide
Breakdown of trials Sanjay Maraboyina has run
Prostate Cancer
Prostate Adenocarcinoma
Lung Cancer
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sanjay Maraboyina specialize in?
Sanjay Maraboyina focuses on Prostate Cancer and Prostate Adenocarcinoma. In particular, much of their work with Prostate Cancer has involved treating patients, or patients who are undergoing treatment.
Is Sanjay Maraboyina currently recruiting for clinical trials?
Yes, Sanjay Maraboyina is currently recruiting for 4 clinical trials in Little Rock Arkansas. If you're interested in participating, you should apply.
Are there any treatments that Sanjay Maraboyina has studied deeply?
Yes, Sanjay Maraboyina has studied treatments such as Stereotactic Body Radiation Therapy, Atezolizumab, Apalutamide.
What is the best way to schedule an appointment with Sanjay Maraboyina?
Apply for one of the trials that Sanjay Maraboyina is conducting.
What is the office address of Sanjay Maraboyina?
The office of Sanjay Maraboyina is located at: University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205 United States. This is the address for their practice at the University of Arkansas for Medical Sciences.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.